Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Men and women need different facial rejuvenation treatments due to distinct aging processes and anatomical differences.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Some supplements and hormones can increase hair loss by raising DHT levels.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.